Last update: May 17th 2013
April 23th 2013

Choose Transparency: A message to the Members...

The Clinical Trial Regulation is currently being discussed. As patients, researchers, doctors, scientists and civil society representatives we would like to draw your attention not only to the dangers it encompasses but also to the opportunities it brings along.

April 09th 2013

Clinical Trials Regulation Protect public...

The International Society of Drug Bulletins issued a statement today to the members of European Parlament to request:

  • support amendments that require the public disclosure of a complete clinical studyreport (CSR) as outlined by ENVI rapporteur MEP...
February 05th 2013

New Proposal for a Regulation on Clinical Trials

The protection of human subjects must be upheld & citizens’ right to information must be strengthened

September 15th 2012

European Medicines Agency and...

On 18 June 2012, the EU Commission published a draft concept paper for public consultation on the “Introduction of fees to be charged by the European Medicines Agency for pharmacovigilance”.

for members only

Press Release - EMEA & other regulatory issues

August 16th 2012

Black triangle for medicines: positive move but poor implementation plan

The draft paper on the quality review of documentssubmitted for consultation by the EMA does not reflect the spirit of the new pharmacovigilance legislation, which is to prevent druginduced harm.

read (264 KB)

Latest Press Release

ISDB - International Society of Drug bullettins

Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it

© 2013